title: [Advances in perioperative antiviral therapy for HBV/HCV-associated hepatocellular carcinoma].
abstract: Chronic viral hepatitis has a high prevalence rate in China, and the presence or absence of hepatitis virus replication is closely associated with the surgical outcome of patients. Therefore, perioperative antiviral therapy becomes an important method for improving patients' outcome. On the basis of treatment modalities and features of different viral infections, this article elaborates on the strategies and effects of perioperative antiviral therapy, in order to guide clinical practice and improve patients' prognosis.
authors.affiliation: Center for Hepatobillary and Pancreatic Diseases, Beijing Tsinghua Changgeng Hospital, Medical Center, Tsinghua University, Beijing 102218, China.
authors.forename: Y
authors.initials: Y
authors.lastname: Huang
authors.forename: J H
authors.initials: JH
authors.lastname: Dong
mesh_terms: D000998:Antiviral Agents / Q000008:administration & dosage*; D006528:Carcinoma, Hepatocellular / Q000601:surgery* / Q000821:virology*; D002681:China; D006509:Hepatitis B / Q000188:drug therapy*; D006526:Hepatitis C / Q000188:drug therapy*; D006801:Humans; D008113:Liver Neoplasms / Q000601:surgery* / Q000821:virology*; D015995:Prevalence; D011379:Prognosis; D016896:Treatment Outcome; D014779:Virus Replication
chemical_list: D000998:Antiviral Agents
keywords: Antiviral therapy; Hepatitis, viral; Perioperative treatment